Neuronetics, Inc.
US ˙ NasdaqGM ˙ US64131A1051

Introduzione

Questa pagina fornisce un'analisi completa dello storico delle operazioni di insider trading note di Wilfred E Jaeger. Gli insider sono funzionari, direttori o investitori importanti di una società. In generale, è illegale per gli insider effettuare operazioni di compravendita nelle loro aziende sulla base di informazioni materiali non pubbliche. Ciò non significa che sia illegale per loro effettuare qualsiasi operazioni di trading nelle proprie aziende. Tuttavia, devono segnalare tutte le operazioni alla SEC tramite un modulo 4. Nonostante queste restrizioni, la ricerca accademica suggerisce che gli insider, in generale, tendono a sovraperformare il mercato nelle proprie società.

Redditività media delle transazioni

La redditività media delle transazioni è il rendimento medio di tutti gli acquisti effettuati sul mercato aperto dagli insider negli ultimi tre anni. Pe calcolarla, esaminiamo tutti gli acquisti non pianificati effettuati dall'insider sul mercato aperto, escludendo tutte le operazioni che sono state parte di un piano di trading 10b5-1. Calcoliamo quindi la performance media di queste operazioni nell'arco di 3, 6 e 12 mesi e facciamo la media di ciascuna di queste durate per generare un indicatore di performance finale per ogni operazione. Infine, facciamo la media di tutti gli indicatori di performance per calcolare un indicatore di performance per l'insider. Questo elenco comprende solo gli insider che hanno effettuato almeno tre operazioni negli ultimi due anni.

Se la redditività delle operazioni di questo insider è "N/D", l'insider non ha effettuato acquisti sul mercato aperto negli ultimi tre anni, oppure le operazioni effettuate sono troppo recenti per poter calcolare un indicatore di performance affidabile.

Frequenza di aggiornamento: giornaliera

Vedi l'elenco degli insider trader più redditizi

Società con posizioni di insider dichiarate

I depositi SEC indicano che Wilfred E Jaeger ha dichiarato partecipazioni o transazioni nelle seguenti società:

Titolo Ruolo Ultime partecipazioni dichiarate
US:STIM / Neuronetics, Inc. Director 138.563
US:CNCE / Concert Pharmaceuticals Inc Director 0
US:NVRO / Nevro Corp. Director 9.592
US:ACRX / Talphera, Inc. 10% Owner 0
US:THLD / Threshold Pharmaceuticals, Inc. Director 35.000
US:LPDX / Liposcience Inc 10% Owner 0
Come interpretare i grafici

I grafici seguenti mostrano l'andamento dei titoli dopo ogni operazione di mercato aperto non pianificata effettuata da Wilfred E Jaeger. Per operazioni non pianificate si intendono operazioni non effettuate nell'ambito di un piano di trading 10b5-1. La performance dei titoli è rappresentata come variazione percentuale cumulativa del prezzo delle azioni. Ad esempio, se un'operazione di insider è stata effettuata il 1° gennaio 2019, il grafico mostrerà la variazione percentuale giornaliera del titolo fino ad oggi. Se il prezzo dell'azione passasse da 10 a 15 dollari durante questo periodo, la variazione percentuale cumulativa del prezzo dell'azione sarebbe del 50%. Una variazione di prezzo da 10 a 20 dollari sarebbe del 100%, mentre una variazione di prezzo da 10 a 5 dollari sarebbe del -50%.

In definitiva, cerchiamo di determinare la correlazione tra le operazioni dell'insider e i rendimenti in eccesso (positivi o negativi) del prezzo dell'azione, al fine di capire se l'insider sta programmando le proprie operazioni per trarre profitto da informazioni privilegiate. Immaginiamo che un insider stia facendo questo. In questa situazione, ci aspetteremmo (a) rendimenti positivi dopo gli acquisti, oppure (b) rendimenti negativi dopo le vendite. Nel caso (a), il grafico ACQUISTO mostrerebbe una serie di curve ascendenti, indicando rendimenti positivi dopo ogni operazione di acquisto. Nel caso (b), il grafico VENDITA mostrerebbe una serie di curve inclinate verso il basso, indicando rendimenti negativi dopo ogni operazione di vendita.

Tuttavia, questo non è sufficiente per trarre conclusioni. Se, ad esempio, il prezzo delle azioni della società è aumentato in maniera non ciclica per molti anni, allora ci aspetteremmo che tutti i grafici post-acquisto abbiano una pendenza rivolta verso l'alto. Allo stesso modo, ribassi non ciclici per molti anni darebbero luogo a grafici post-negoziazione rivolti verso il basso. Nessuno di questi grafici suggerisce un'attività di insider trading.

L'indicatore più forte sarebbe una situazione in cui il prezzo delle azioni fosse estremamente ciclico e vi fossero segnali positivi nel grafico ACQUISTO e curve negative nel grafico VENDITA. Questa situazione suggerirebbe che l'insider sta programmando le operazioni di trading per trarne un vantaggio finanziario.

Acquisti di insider STIM / Neuronetics, Inc. - Analisi degli utili a breve termine

In questa sezione analizziamo la redditività di ogni acquisto non pianificato di insider sul mercato aperto effettuato in STIM / Neuronetics, Inc.. Questa analisi aiuta a capire se l'insider genera costantemente rendimenti anomali e se vale la pena seguirlo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.

La tabella seguente mostra gli acquisti più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.

Data dell'operazione Ticker Insider Azioni
dichiarate
Prezzo
dichiarato
Azioni
rettificate
Prezzo
rettificato
Base di costo Giorni fino al
massimo
Prezzo al
massimo
Profitto
massimo ($)
Rendimento massimo (%)
2018-07-02 STIM JAEGER WILFRED E 6.667 17,0000 6.667 17,0000 113.339 70 37.54 136.940 120,82

Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.

STIM / Neuronetics, Inc. Insider Trades
Vendite di insider STIM / Neuronetics, Inc. - Analisi delle perdite a breve termine

In questa sezione, analizziamo l'evitamento delle perdite a breve termine di ogni vendita di insider non pianificata ed effettuata sul mercato aperto in STIM / Neuronetics, Inc.. Un modello coerente di evitamento delle perdite può suggerire che future transazioni di vendita potrebbero predire cali di prezzo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.

La tabella seguente mostra le vendite più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.

Data dell'operazione Ticker Insider Azioni
dichiarate
Prezzo
dichiarato
Azioni
rettificate
Prezzo
rettificato
Base di costo Giorni fino al
minimo
Prezzo al
minimo
Perdita massima
evitata ($)
Perdita massima
evitata (%)
Non sono note operazioni di mercato aperto non pianificate per questa combinazione di insider e titoli.

Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.

STIM / Neuronetics, Inc. Insider Trades
Acquisti di insider TLPH / Talphera, Inc. - Analisi degli utili a breve termine

In questa sezione analizziamo la redditività di ogni acquisto non pianificato di insider sul mercato aperto effettuato in STIM / Neuronetics, Inc.. Questa analisi aiuta a capire se l'insider genera costantemente rendimenti anomali e se vale la pena seguirlo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.

La tabella seguente mostra gli acquisti più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.

Data dell'operazione Ticker Insider Azioni
dichiarate
Prezzo
dichiarato
Azioni
rettificate
Prezzo
rettificato
Base di costo Giorni fino al
massimo
Prezzo al
massimo
Profitto
massimo ($)
Rendimento massimo (%)
2012-12-07 ACRX WAN MARK A 2.364.705 3,3100 118.235 66,2000 7.827.174 227 262.4 23.197.691 296,37
2012-12-07 ACRX WAN MARK A 52.213 3,3100 2.611 66,2000 172.825
2012-05-29 ACRX WAN MARK A 67.543 3,4000 3.377 68,0000 229.646
2012-05-29 ACRX WAN MARK A 3.631 3,4000 182 68,0000 12.345
2012-05-29 ACRX WAN MARK A 208.911 3,4000 10.446 68,0000 710.297
2012-05-29 ACRX WAN MARK A 4.613 3,4000 231 68,0000 15.684

Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.

TLPH / Talphera, Inc. Insider Trades
Vendite di insider TLPH / Talphera, Inc. - Analisi delle perdite a breve termine

In questa sezione, analizziamo l'evitamento delle perdite a breve termine di ogni vendita di insider non pianificata ed effettuata sul mercato aperto in STIM / Neuronetics, Inc.. Un modello coerente di evitamento delle perdite può suggerire che future transazioni di vendita potrebbero predire cali di prezzo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.

La tabella seguente mostra le vendite più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.

Data dell'operazione Ticker Insider Azioni
dichiarate
Prezzo
dichiarato
Azioni
rettificate
Prezzo
rettificato
Base di costo Giorni fino al
minimo
Prezzo al
minimo
Perdita massima
evitata ($)
Perdita massima
evitata (%)
Non sono note operazioni di mercato aperto non pianificate per questa combinazione di insider e titoli.

Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.

TLPH / Talphera, Inc. Insider Trades
Storico delle operazioni degli insider

Questa tabella mostra l'elenco completo delle operazioni effettuate da Wilfred E Jaeger come comunicato alla Securities Exchange Commission (SEC).

Data di deposito Data della transazione Modulo Ticker Titolo Codice 10b5-1 Azioni Azioni rimanenti Variazione
percentuale
Prezzo
dell'azione
Valore
della transazione
Valore
rimanente
2023-05-30 2023-05-25 4 STIM Neuronetics, Inc.
Common Stock
A - Award 36.364 138.563 35,58
2023-03-06 2023-03-06 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
D - Sale to Issuer -16.400 0 -100,00
2023-03-06 2023-03-06 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
U - Other -5.125 0 -100,00
2022-06-13 2022-06-09 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
A - Award 16.400 21.525 320,00
2022-05-31 2022-05-26 4 STIM Neuronetics, Inc.
Common Stock
A - Award 38.910 102.187 61,49
2021-06-11 2021-06-10 4 CNCE CONCERT PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 10.250 10.250
2021-06-11 2021-06-10 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
A - Award 5.125 5.125
2021-06-01 2021-05-27 4 STIM Neuronetics, Inc.
Common Stock
A - Award 7.137 63.289 12,71
2020-08-07 2020-08-05 4 STIM Neuronetics, Inc.
Common Stock
A - Award 18.513 56.152 49,19
2020-06-12 2020-06-11 4 CNCE CONCERT PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 10.000 10.000
2020-05-28 2020-05-26 4 STIM Neuronetics, Inc.
Common Stock
A - Award 20.000 37.639 113,39
2020-05-26 2020-05-21 4 NVRO NEVRO CORP
Common Stock
A - Award 1.376 9.592 16,75
2020-02-14 2018-05-09 5 NVRO NEVRO CORP
Common Stock
J - Other 2.085 3.106 204,21
2020-02-14 2018-05-09 5 NVRO NEVRO CORP
Common Stock
J - Other 2.085 3.106 204,21
2020-02-14 2018-05-09 5 NVRO NEVRO CORP
Common Stock
J - Other 714 25.341 2,90
2020-02-14 2018-05-09 5 NVRO NEVRO CORP
Common Stock
J - Other 16.302 25.341 180,35
2020-02-14 2017-11-29 5 NVRO NEVRO CORP
Common Stock
J - Other 1.021 3.106 48,97
2020-02-14 2017-11-29 5 NVRO NEVRO CORP
Common Stock
J - Other 1.021 3.106 48,97
2020-02-14 2017-11-29 5 NVRO NEVRO CORP
Common Stock
J - Other 349 25.341 1,40
2020-02-14 2017-11-29 5 NVRO NEVRO CORP
Common Stock
J - Other 7.976 25.341 45,93
2020-01-06 2020-01-02 4 STIM Neuronetics, Inc.
Common Stock
A - Award 3.062 17.639 21,01 4,49 13.748 79.199
2019-10-03 2019-10-01 4 STIM Neuronetics, Inc.
Common Stock
A - Award 1.957 14.577 15,51 8,30 16.243 120.989
2019-07-02 2019-07-01 4 STIM Neuronetics, Inc.
Common Stock
A - Award 1.298 12.620 11,46 12,51 16.238 157.876
2019-06-17 2019-06-13 4 CNCE CONCERT PHARMACEUTICALS, INC.
Nonstatutory Stock Option (Right to Buy)
A - Award 10.000 10.000
2019-05-30 2019-05-28 4 STIM Neuronetics, Inc.
Stock Option (right to buy)
A - Award 7.347 7.347
2019-05-30 2019-05-28 4 STIM Neuronetics, Inc.
Common Stock
A - Award 3.723 11.322 48,99
2019-05-22 2019-05-20 4 NVRO NEVRO CORP
Common Stock
A - Award 2.913 8.216 54,93
2019-04-03 2019-04-01 4 STIM Neuronetics, Inc.
Common Stock
A - Award 932 7.599 13,98 14,75 13.747 112.085
2018-07-05 2018-07-02 4 STIM Neuronetics, Inc.
Stock Option (Right to Buy)
A - Award 8.767 8.767
2018-07-05 2018-07-02 4 STIM Neuronetics, Inc.
Common Stock
P - Purchase 6.667 6.667 17,00 113.339 113.339
2018-06-18 2018-06-14 4 CNCE CONCERT PHARMACEUTICALS, INC.
Nonstatutory Stock Option (Right to Buy)
A - Award 10.000 10.000
2018-05-23 2018-05-21 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock
J - Other -126.153 0 -100,00
2018-05-23 2018-05-21 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock
J - Other -5.713.569 0 -100,00
2018-05-23 2018-05-21 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock
J - Other -179.962 0 -100,00
2018-05-23 2018-05-21 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock
J - Other -3.347.357 0 -100,00
2018-05-23 2018-05-21 4 NVRO NEVRO CORP
Common Stock
A - Award 3.785 5.303 249,34
2018-03-07 2018-03-07 4 NVRO NEVRO CORP
Common Stock
S - Sale -1.461 11.042 -11,69 81,42 -118.958 899.064
2018-03-07 2018-03-07 4 NVRO NEVRO CORP
Common Stock
S - Sale -66.125 500.109 -11,68 81,42 -5.384.043 40.719.975
2018-03-07 2018-03-06 4 NVRO NEVRO CORP
Common Stock
S - Sale -1.098 12.503 -8,07 80,38 -88.258 1.005.000
2018-03-07 2018-03-06 4 NVRO NEVRO CORP
Common Stock
S - Sale -49.742 566.234 -8,08 80,38 -3.998.297 45.514.285
2018-03-07 2018-03-05 4 NVRO NEVRO CORP
Common Stock
S - Sale -910 13.601 -6,27 80,19 -72.969 1.090.610
2018-03-07 2018-03-05 4 NVRO NEVRO CORP
Common Stock
S - Sale -41.206 615.976 -6,27 80,19 -3.304.144 49.392.652
2018-03-01 2018-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale -216 14.511 -1,47 80,48 -17.385 1.167.908
2018-03-01 2018-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale -9.784 657.182 -1,47 80,48 -787.458 52.892.833
2018-03-01 2018-02-28 4 NVRO NEVRO CORP
Common Stock
S - Sale -151 14.727 -1,01 81,36 -12.286 1.198.226
2018-03-01 2018-02-28 4 NVRO NEVRO CORP
Common Stock
S - Sale -6.832 666.966 -1,01 81,36 -555.869 54.266.021
2018-03-01 2018-02-28 4 NVRO NEVRO CORP
Common Stock
S - Sale -173 14.878 -1,15 83,09 -14.375 1.236.276
2018-03-01 2018-02-28 4 NVRO NEVRO CORP
Common Stock
S - Sale -7.844 673.798 -1,15 83,09 -651.791 55.988.706
2018-03-01 2018-02-27 4 NVRO NEVRO CORP
Common Stock
S - Sale -286 15.051 -1,86 83,20 -23.795 1.252.212
2018-03-01 2018-02-27 4 NVRO NEVRO CORP
Common Stock
S - Sale -12.972 681.642 -1,87 83,20 -1.079.243 56.711.183
2018-03-01 2018-02-27 4 NVRO NEVRO CORP
Common Stock
S - Sale -26 15.337 -0,17 84,17 -2.188 1.290.954
2018-03-01 2018-02-27 4 NVRO NEVRO CORP
Common Stock
S - Sale -1.174 694.614 -0,17 84,17 -98.819 58.467.397
2017-09-18 2017-09-14 4 NVRO NEVRO CORP
Common Stock
S - Sale -286 20.764 -1,36 90,31 -25.829 1.875.201
2017-09-18 2017-09-14 4 NVRO NEVRO CORP
Common Stock
S - Sale -12.935 940.387 -1,36 90,31 -1.168.162 84.926.538
2017-09-18 2017-09-14 4 NVRO NEVRO CORP
Common Stock
S - Sale -70 21.050 -0,33 89,72 -6.280 1.888.503
2017-09-18 2017-09-14 4 NVRO NEVRO CORP
Common Stock
S - Sale -3.176 953.322 -0,33 89,72 -284.935 85.527.379
2017-08-24 2017-08-24 4 NVRO NEVRO CORP
Common Stock
S - Sale -158 21.120 -0,74 87,00 -13.746 1.837.440
2017-08-24 2017-08-24 4 NVRO NEVRO CORP
Common Stock
S - Sale -7.156 956.498 -0,74 87,00 -622.572 83.215.326
2017-08-24 2017-08-23 4 NVRO NEVRO CORP
Common Stock
S - Sale -112 21.278 -0,52 87,01 -9.745 1.851.433
2017-08-24 2017-08-23 4 NVRO NEVRO CORP
Common Stock
S - Sale -5.094 963.654 -0,53 87,01 -443.237 83.849.076
2017-08-24 2017-08-22 4 NVRO NEVRO CORP
Common Stock
S - Sale -432 21.390 -1,98 86,48 -37.360 1.849.820
2017-08-24 2017-08-22 4 NVRO NEVRO CORP
Common Stock
S - Sale -19.568 968.748 -1,98 86,48 -1.692.252 83.777.908
2017-08-24 2017-08-22 4 NVRO NEVRO CORP
Common Stock
S - Sale -432 21.822 -1,94 85,17 -36.795 1.858.650
2017-08-24 2017-08-22 4 NVRO NEVRO CORP
Common Stock
S - Sale -19.568 988.316 -1,94 85,17 -1.666.669 84.178.036
2017-08-21 2017-08-21 4 NVRO NEVRO CORP
Common Stock
S - Sale -540 22.254 -2,37 84,44 -45.600 1.879.228
2017-08-21 2017-08-21 4 NVRO NEVRO CORP
Common Stock
S - Sale -24.460 1.007.884 -2,37 84,44 -2.065.512 85.110.260
2017-08-21 2017-08-17 4 NVRO NEVRO CORP
Common Stock
S - Sale -331 22.794 -1,43 84,02 -27.810 1.915.125
2017-08-21 2017-08-17 4 NVRO NEVRO CORP
Common Stock
S - Sale -15.012 1.032.344 -1,43 84,02 -1.261.290 86.736.304
2017-08-16 2017-08-16 4 NVRO NEVRO CORP
Common Stock
S - Sale -236 23.125 -1,01 84,04 -19.834 1.943.462
2017-08-16 2017-08-16 4 NVRO NEVRO CORP
Common Stock
S - Sale -10.701 1.047.356 -1,01 84,04 -899.329 88.021.474
2017-08-16 2017-08-16 4 NVRO NEVRO CORP
Common Stock
S - Sale -299 23.361 -1,26 82,75 -24.743 1.933.155
2017-08-16 2017-08-16 4 NVRO NEVRO CORP
Common Stock
S - Sale -13.501 1.058.057 -1,26 82,75 -1.117.227 87.555.698
2017-08-16 2017-08-15 4 NVRO NEVRO CORP
Common Stock
S - Sale -641 23.660 -2,64 82,54 -52.905 1.952.797
2017-08-16 2017-08-15 4 NVRO NEVRO CORP
Common Stock
S - Sale -29.024 1.071.558 -2,64 82,54 -2.395.519 88.441.897
2017-08-16 2017-08-14 4 NVRO NEVRO CORP
Common Stock
S - Sale -546 24.301 -2,20 82,40 -44.991 2.002.407
2017-08-16 2017-08-14 4 NVRO NEVRO CORP
Common Stock
S - Sale -24.709 1.100.582 -2,20 82,40 -2.036.027 90.688.177
2017-06-19 2017-06-15 4 CNCE CONCERT PHARMACEUTICALS, INC.
Nonstatutory Stock Option (right to buy)
A - Award 10.000 10.000
2017-05-30 2017-05-25 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
A - Award 3.545 3.545
2017-05-30 2017-05-25 4 NVRO NEVRO CORP
Common Stock
A - Award 1.518 1.518
2017-03-03 2017-03-03 4 NVRO NEVRO CORP
Common Stock
S - Sale -16 24.847 -0,06 95,00 -1.520 2.360.465
2017-03-03 2017-03-03 4 NVRO NEVRO CORP
Common Stock
S - Sale -703 1.125.291 -0,06 95,00 -66.785 106.902.645
2017-03-03 2017-03-02 4 NVRO NEVRO CORP
Common Stock
S - Sale -6 24.863 -0,02 95,00 -570 2.361.985
2017-03-03 2017-03-02 4 NVRO NEVRO CORP
Common Stock
S - Sale -294 1.125.994 -0,03 95,00 -27.930 106.969.430
2017-03-03 2017-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale -928 24.869 -3,60 95,03 -88.191 2.363.383
2017-03-03 2017-03-01 4 NVRO NEVRO CORP
Common Stock
S - Sale -42.033 1.126.288 -3,60 95,03 -3.994.535 107.034.865
2016-08-22 2016-08-22 4 NVRO NEVRO CORP
Common Stock
S - Sale -79 25.797 -0,31 99,89 -7.891 2.576.847
2016-08-22 2016-08-22 4 NVRO NEVRO CORP
Common Stock
S - Sale -137 25.876 -0,53 98,58 -13.505 2.550.727
2016-08-22 2016-08-22 4 NVRO NEVRO CORP
Common Stock
S - Sale -3.567 1.168.321 -0,30 99,89 -356.305 116.702.884
2016-08-22 2016-08-22 4 NVRO NEVRO CORP
Common Stock
S - Sale -6.217 1.171.888 -0,53 98,58 -612.841 115.518.860
2016-08-22 2016-08-19 4 NVRO NEVRO CORP
Common Stock
S - Sale -370 26.013 -1,40 98,30 -36.372 2.557.161
2016-08-22 2016-08-19 4 NVRO NEVRO CORP
Common Stock
S - Sale -1.034 26.383 -3,77 97,86 -101.192 2.581.964
2016-08-22 2016-08-19 4 NVRO NEVRO CORP
Common Stock
S - Sale -16.753 1.178.105 -1,40 98,30 -1.646.874 115.811.491
2016-08-22 2016-08-19 4 NVRO NEVRO CORP
Common Stock
S - Sale -46.843 1.194.858 -3,77 97,86 -4.584.276 116.934.420
2016-08-22 2016-08-18 4 NVRO NEVRO CORP
Common Stock
S - Sale -50 27.417 -0,18 98,14 -4.907 2.690.608
2016-08-22 2016-08-18 4 NVRO NEVRO CORP
Common Stock
S - Sale -1.459 27.467 -5,04 97,53 -142.300 2.678.922
2016-08-22 2016-08-18 4 NVRO NEVRO CORP
Common Stock
S - Sale -216 28.926 -0,74 96,88 -20.926 2.802.391
2016-08-22 2016-08-18 4 NVRO NEVRO CORP
Common Stock
S - Sale -2.250 1.241.701 -0,18 98,14 -220.807 121.856.190
2016-08-22 2016-08-18 4 NVRO NEVRO CORP
Common Stock
S - Sale -66.066 1.243.951 -5,04 97,53 -6.443.576 121.325.527
2016-08-22 2016-08-18 4 NVRO NEVRO CORP
Common Stock
S - Sale -9.799 1.310.017 -0,74 96,88 -949.341 126.916.281
2016-08-17 2016-08-17 4 NVRO NEVRO CORP
Common Stock
S - Sale -661 29.142 -2,22 96,16 -63.559 2.802.161
2016-08-17 2016-08-17 4 NVRO NEVRO CORP
Common Stock
S - Sale -29.953 1.319.816 -2,22 96,16 -2.880.143 126.907.435
2016-08-17 2016-08-16 4 NVRO NEVRO CORP
Common Stock
S - Sale -73 29.803 -0,24 97,06 -7.086 2.892.801
2016-08-17 2016-08-16 4 NVRO NEVRO CORP
Common Stock
S - Sale -457 29.876 -1,51 96,02 -43.880 2.868.601
2016-08-17 2016-08-16 4 NVRO NEVRO CORP
Common Stock
S - Sale -3.327 1.349.769 -0,25 97,06 -322.932 131.014.113
2016-08-17 2016-08-16 4 NVRO NEVRO CORP
Common Stock
S - Sale -20.689 1.353.096 -1,51 96,02 -1.986.494 129.920.083
2016-08-17 2016-08-15 4 NVRO NEVRO CORP
Common Stock
S - Sale -121 30.333 -0,40 98,66 -11.938 2.992.608
2016-08-17 2016-08-15 4 NVRO NEVRO CORP
Common Stock
S - Sale -2.039 30.454 -6,28 97,90 -199.617 2.981.437
2016-08-17 2016-08-15 4 NVRO NEVRO CORP
Common Stock
S - Sale -5.487 1.373.785 -0,40 98,66 -541.339 135.535.567
2016-08-17 2016-08-15 4 NVRO NEVRO CORP
Common Stock
S - Sale -92.353 1.379.272 -6,28 97,90 -9.041.331 135.030.315
2016-06-28 2016-06-24 4 THLD THRESHOLD PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 35.000 35.000
2016-06-10 2016-06-09 4 CNCE CONCERT PHARMACEUTICALS, INC.
Nonstatutory Stock Option (right to buy)
A - Award 10.000 10.000
2016-05-20 2016-05-18 4 NVRO NEVRO CORP
Stock Option (Right to Buy)
A - Award 3.240 3.240
2016-05-19 2016-05-18 4 NVRO NEVRO CORP
Common Stock
S - Sale -29 32.493 -0,09 64,02 -1.857 2.080.182
2016-05-19 2016-05-18 4 NVRO NEVRO CORP
Common Stock
S - Sale -1.314 1.471.625 -0,09 64,02 -84.121 94.212.550
2016-05-19 2016-05-17 4 NVRO NEVRO CORP
Common Stock
S - Sale -78 32.522 -0,24 65,54 -5.112 2.131.365
2016-05-19 2016-05-17 4 NVRO NEVRO CORP
Common Stock
S - Sale -174 32.600 -0,53 64,01 -11.137 2.086.628
2016-05-19 2016-05-17 4 NVRO NEVRO CORP
Common Stock
S - Sale -3.522 1.472.939 -0,24 65,54 -230.818 96.530.678
2016-05-19 2016-05-17 4 NVRO NEVRO CORP
Common Stock
S - Sale -7.866 1.476.461 -0,53 64,01 -503.479 94.503.839
2016-05-19 2016-05-16 4 NVRO NEVRO CORP
Common Stock
S - Sale -91 32.774 -0,28 65,47 -5.957 2.145.609
2016-05-19 2016-05-16 4 NVRO NEVRO CORP
Common Stock
S - Sale -2.069 32.865 -5,92 64,68 -133.813 2.125.544
2016-05-19 2016-05-16 4 NVRO NEVRO CORP
Common Stock
S - Sale -4.140 1.484.327 -0,28 65,47 -271.033 97.174.139
2016-05-19 2016-05-16 4 NVRO NEVRO CORP
Common Stock
S - Sale -93.700 1.488.467 -5,92 64,68 -6.060.048 96.266.603
2016-03-01 2015-11-24 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
J - Other -27.500 52.500 -34,38
2015-12-16 2015-12-16 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -113 0 -100,00 19,57 -2.211
2015-12-16 2015-12-16 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -5.066 0 -100,00 19,57 -99.119
2015-12-16 2015-12-16 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -265 0 -100,00 19,57 -5.185
2015-12-16 2015-12-16 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -4.916 0 -100,00 19,57 -96.184
2015-12-16 2015-12-15 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -589 113 -83,90 20,10 -11.841 2.272
2015-12-16 2015-12-15 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -26.697 5.066 -84,05 20,10 -536.719 101.847
2015-12-16 2015-12-15 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.392 265 -84,01 20,10 -27.985 5.328
2015-12-16 2015-12-15 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -25.894 4.916 -84,04 20,10 -520.576 98.832
2015-12-16 2015-12-14 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -42 702 -5,65 20,09 -844 14.102
2015-12-16 2015-12-14 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.919 31.763 -5,70 20,09 -38.549 638.058
2015-12-16 2015-12-14 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -100 1.657 -5,69 20,09 -2.009 33.286
2015-12-16 2015-12-14 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.861 30.810 -5,70 20,09 -37.384 618.914
2015-11-24 2015-11-23 4 NVRO NEVRO CORP
Common Stock
S - Sale -540 34.934 -1,52 53,48 -28.880 1.868.312
2015-11-24 2015-11-23 4 NVRO NEVRO CORP
Common Stock
S - Sale -24.460 1.582.167 -1,52 53,48 -1.308.150 84.616.190
2015-11-19 2015-11-18 4 NVRO NEVRO CORP
Common Stock
S - Sale -696 35.474 -1,92 53,16 -36.999 1.885.773
2015-11-19 2015-11-18 4 NVRO NEVRO CORP
Common Stock
S - Sale -2.040 36.170 -5,34 52,08 -106.237 1.883.618
2015-11-19 2015-11-18 4 NVRO NEVRO CORP
Common Stock
S - Sale -31.496 1.606.627 -1,92 53,16 -1.674.305 85.407.167
2015-11-19 2015-11-18 4 NVRO NEVRO CORP
Common Stock
S - Sale -92.400 1.638.123 -5,34 52,08 -4.811.896 85.308.204
2015-11-19 2015-11-17 4 NVRO NEVRO CORP
Common Stock
S - Sale -1.045 38.210 -2,66 51,94 -54.276 1.984.589
2015-11-19 2015-11-17 4 NVRO NEVRO CORP
Common Stock
S - Sale -47.323 1.730.523 -2,66 51,94 -2.457.909 89.881.634
2015-09-14 2015-09-10 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.296 744 -63,53 18,22 -23.613 13.556
2015-09-14 2015-09-10 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -58.704 33.682 -63,54 18,22 -1.069.587 613.686
2015-09-14 2015-09-10 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -3.062 1.757 -63,54 18,22 -55.790 32.013
2015-09-14 2015-09-10 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -56.938 32.671 -63,54 18,22 -1.037.410 595.266
2015-08-18 2015-08-18 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -6.805 2.040 -76,94 15,70 -106.838 32.028
2015-08-18 2015-08-18 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -308.195 92.386 -76,94 15,70 -4.838.662 1.450.460
2015-08-18 2015-08-18 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -16.071 4.819 -76,93 15,70 -252.315 75.658
2015-08-18 2015-08-18 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -298.929 89.609 -76,94 15,70 -4.693.185 1.406.861
2015-08-18 2015-08-14 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.404 8.845 -13,70 16,32 -22.913 144.350
2015-08-18 2015-08-14 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -63.596 400.581 -13,70 16,32 -1.037.887 6.537.482
2015-08-18 2015-08-14 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -3.316 20.890 -13,70 16,32 -54.117 340.925
2015-08-18 2015-08-14 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -61.684 388.538 -13,70 16,32 -1.006.683 6.340.940
2015-08-17 2015-08-13 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -996 10.249 -8,86 16,75 -16.683 171.671
2015-08-17 2015-08-13 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -45.112 464.177 -8,86 16,75 -755.626 7.774.965
2015-08-17 2015-08-13 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -2.352 24.206 -8,86 16,75 -39.396 405.450
2015-08-17 2015-08-13 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -43.755 450.222 -8,86 16,75 -732.896 7.541.218
2015-08-14 2015-08-12 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.056 11.245 -8,58 14,49 -15.301 162.937
2015-08-14 2015-08-12 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -47.837 509.289 -8,59 14,49 -693.144 7.379.445
2015-08-14 2015-08-12 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -2.494 26.558 -8,58 14,49 -36.137 384.817
2015-08-14 2015-08-12 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -46.398 493.977 -8,59 14,49 -672.293 7.157.579
2015-08-14 2015-08-12 4/A CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -1.056 11.245 -8,58 17,49 -18.469 196.672
2015-08-14 2015-08-12 4/A CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -47.837 509.289 -8,59 17,49 -836.655 8.907.312
2015-08-14 2015-08-12 4/A CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -2.494 26.558 -8,58 17,49 -43.619 464.491
2015-08-14 2015-08-12 4/A CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -46.398 493.977 -8,59 17,49 -811.487 8.639.510
2015-07-06 2015-05-26 4 THLD THRESHOLD PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 20.000 20.000
2015-06-15 2015-06-11 4 CNCE CONCERT PHARMACEUTICALS, INC.
Nonstatutory Stock Option (right to buy)
A - Award 10.000 10.000
2015-06-08 2015-06-08 4 NVRO NEVRO CORP
Common Stock
S - Sale -8.500 39.255 -17,80 47,94 -407.490 1.881.885
2015-06-08 2015-06-08 4 NVRO NEVRO CORP
Common Stock
S - Sale -384.968 1.777.846 -17,80 47,94 -18.455.366 85.229.937
2015-06-01 2015-05-28 4 NVRO NEVRO CORP
Stock Option (right to buy)
A - Award 4.182 4.182
2015-02-20 2015-02-18 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock Warrant (Right to Buy)
P - Purchase 25.000 25.000
2015-02-20 2015-02-18 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
P - Purchase 25.000 80.000 45,45 3,74 93.625 299.600
2014-11-20 2014-11-18 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -5.400 12.301 -30,51 12,29 -66.366 151.179
2014-11-20 2014-11-18 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -244.600 557.126 -30,51 12,29 -3.006.134 6.847.079
2014-11-20 2014-11-18 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -12.755 29.052 -30,51 12,29 -156.759 357.049
2014-11-20 2014-11-18 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
S - Sale -237.245 540.375 -30,51 12,29 -2.915.741 6.641.209
2014-11-12 2014-11-12 4 NVRO NEVRO CORP
Series C Preferred Stock
C - Conversion -4.506 0 -100,00
2014-11-12 2014-11-12 4 NVRO NEVRO CORP
Series B Preferred Stock
C - Conversion -15.069 0 -100,00
2014-11-12 2014-11-12 4 NVRO NEVRO CORP
Series A Preferred Stock
C - Conversion -28.090 0 -100,00
2014-11-12 2014-11-12 4 NVRO NEVRO CORP
Series C Preferred Stock
C - Conversion -204.076 0 -100,00
2014-11-12 2014-11-12 4 NVRO NEVRO CORP
Series B Preferred Stock
C - Conversion -682.475 0 -100,00
2014-11-12 2014-11-12 4 NVRO NEVRO CORP
Series A Preferred Stock
C - Conversion -1.272.187 0 -100,00
2014-11-12 2014-11-12 4 NVRO NEVRO CORP
Common Stock
C - Conversion 4.506 47.755 10,42
2014-11-12 2014-11-12 4 NVRO NEVRO CORP
Common Stock
C - Conversion 15.069 43.249 53,47
2014-11-12 2014-11-12 4 NVRO NEVRO CORP
Common Stock
C - Conversion 28.090 28.180 31.211,11
2014-11-12 2014-11-12 4 NVRO NEVRO CORP
Common Stock
C - Conversion 204.076 2.162.814 10,42
2014-11-12 2014-11-12 4 NVRO NEVRO CORP
Common Stock
C - Conversion 682.475 1.958.738 53,47
2014-11-12 2014-11-12 4 NVRO NEVRO CORP
Common Stock
C - Conversion 1.272.187 1.276.263 31.211,65
2014-11-07 2014-11-05 4 NVRO NEVRO CORP
Stock Option (right to buy)
A - Award 8.477 8.477
2014-11-05 3 NVRO NEVRO CORP
Common Stock
8.242
2014-11-05 3 NVRO NEVRO CORP
Common Stock
4.256
2014-11-05 3 NVRO NEVRO CORP
Common Stock
8.242
2014-11-05 3 NVRO NEVRO CORP
Common Stock
4.256
2014-11-05 3 NVRO NEVRO CORP
Common Stock
8.242
2014-11-05 3 NVRO NEVRO CORP
Common Stock
4.256
2014-11-05 3 NVRO NEVRO CORP
Common Stock
8.242
2014-11-05 3 NVRO NEVRO CORP
Common Stock
4.256
2014-11-05 3 NVRO NEVRO CORP
Common Stock
8.242
2014-11-05 3 NVRO NEVRO CORP
Common Stock
4.256
2014-11-05 3 NVRO NEVRO CORP
Common Stock
8.242
2014-11-05 3 NVRO NEVRO CORP
Common Stock
4.256
2014-05-19 2014-05-16 4 THLD THRESHOLD PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 20.000 20.000
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Series C Convertible Preferred Stock
C - Conversion -391.359 0 -100,00
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Series B Convertible Preferred Stock
C - Conversion -1.956.794 0 -100,00
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Series A Convertible Preferred Stock
C - Conversion -1.467.595 0 -100,00
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Series C Convertible Preferred Stock
C - Conversion -8.641 0 -100,00
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Series B Convertible Preferred Stock
C - Conversion -43.206 0 -100,00
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Series A Convertible Preferred Stock
C - Conversion -32.405 0 -100,00
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
P - Purchase 101.264 801.726 14,46 14,00 1.417.696 11.224.164
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
P - Purchase 2.236 17.701 14,46 14,00 31.304 247.814
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
C - Conversion 69.267 700.462 10,97
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
C - Conversion 346.335 631.195 121,58
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
C - Conversion 259.751 284.860 1.034,49
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
C - Conversion 1.529 15.465 10,97
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
C - Conversion 7.647 13.936 121,59
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
C - Conversion 5.735 6.289 1.035,20
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Series C Convertible Preferred Stock
C - Conversion -379.592 0 -100,00
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Series B Convertible Preferred Stock
C - Conversion -1.897.959 0 -100,00
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Series A Convertible Preferred Stock
C - Conversion -1.423.469 0 -100,00
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Series C Convertible Preferred Stock
C - Conversion -20.408 0 -100,00
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Series B Convertible Preferred Stock
C - Conversion -102.041 0 -100,00
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Series A Convertible Preferred Stock
C - Conversion -76.531 0 -100,00
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
P - Purchase 98.219 777.620 14,46 14,00 1.375.066 10.886.680
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
P - Purchase 5.281 41.807 14,46 14,00 73.934 585.298
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
C - Conversion 67.184 679.401 10,97
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
C - Conversion 335.922 612.217 121,58
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
C - Conversion 251.941 276.295 1.034,50
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
C - Conversion 3.612 36.526 10,97
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
C - Conversion 18.060 32.914 121,58
2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
C - Conversion 13.545 14.854 1.034,76
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
26.217
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
50.772
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
26.217
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
50.772
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
26.217
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
50.772
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
26.217
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
50.772
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
26.217
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
50.772
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
26.217
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
50.772
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
26.972
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
50.017
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
26.972
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
50.017
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
26.972
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
50.017
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
26.972
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
50.017
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
26.972
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
50.017
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
26.972
2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock
50.017
2014-01-17 2014-01-16 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -4.907 0 -100,00 4,86 -23.832
2014-01-17 2014-01-16 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -91.449 0 -100,00 4,86 -444.140
2014-01-15 2014-01-15 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -10.204 4.907 -67,53 4,86 -49.561 23.833
2014-01-15 2014-01-15 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -189.796 91.449 -67,48 4,86 -921.839 444.168
2014-01-15 2014-01-14 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -5.000 15.111 -24,86 4,87 -24.330 73.530
2014-01-15 2014-01-14 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -93.000 281.245 -24,85 4,87 -452.538 1.368.538
2014-01-15 2014-01-13 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -6.477 20.111 -24,36 4,90 -31.705 98.443
2014-01-15 2014-01-13 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -120.479 374.245 -24,35 4,90 -589.745 1.831.929
2014-01-10 2014-01-10 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -14.286 26.588 -34,95 4,87 -69.597 129.529
2014-01-10 2014-01-10 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -265.714 494.724 -34,94 4,87 -1.294.479 2.410.147
2014-01-10 2014-01-09 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -10.204 40.874 -19,98 4,87 -49.668 198.954
2014-01-10 2014-01-09 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -189.796 760.438 -19,97 4,87 -923.832 3.701.432
2014-01-10 2014-01-08 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -12.444 51.078 -19,59 4,90 -60.957 250.206
2014-01-10 2014-01-08 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -231.456 950.234 -19,59 4,90 -1.133.787 4.654.721
2013-07-16 2013-07-15 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -4.552 63.522 -6,69 5,52 -25.118 350.514
2013-07-16 2013-07-15 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -84.648 1.181.690 -6,68 5,52 -467.088 6.520.565
2013-07-16 2013-07-12 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -11.877 68.074 -14,86 5,54 -65.787 377.062
2013-07-16 2013-07-12 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -220.923 1.266.338 -14,85 5,54 -1.223.692 7.014.246
2013-07-12 2013-07-11 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -5.918 79.951 -6,89 5,52 -32.672 441.385
2013-07-12 2013-07-11 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -110.082 1.487.261 -6,89 5,52 -607.730 8.210.722
2013-07-12 2013-07-10 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -3.163 85.869 -3,55 5,50 -17.400 472.374
2013-07-12 2013-07-10 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -58.837 1.597.343 -3,55 5,50 -323.668 8.787.144
2013-07-08 2013-07-05 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -4.897 89.032 -5,21 5,48 -26.836 487.895
2013-07-08 2013-07-05 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -91.070 1.656.180 -5,21 5,48 -499.064 9.075.866
2013-07-08 2013-07-03 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -6.311 93.929 -6,30 5,56 -35.089 522.245
2013-07-08 2013-07-03 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -117.389 1.747.250 -6,30 5,56 -652.683 9.714.710
2013-06-21 2013-06-19 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -102 100.240 -0,10 5,50 -561 551.671
2013-06-21 2013-06-19 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -1.898 1.864.639 -0,10 5,50 -10.446 10.262.041
2013-06-19 2013-06-18 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -3.649 100.342 -3,51 5,50 -20.075 552.021
2013-06-19 2013-06-18 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -67.862 1.866.537 -3,51 5,50 -373.336 10.268.567
2013-06-19 2013-06-17 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -2.715 103.991 -2,54 5,53 -15.006 574.758
2013-06-19 2013-06-17 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -50.507 1.934.399 -2,54 5,53 -279.152 10.691.423
2013-06-11 2013-06-10 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -2.735 106.706 -2,50 5,50 -15.043 586.915
2013-06-11 2013-06-10 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -50.865 1.984.906 -2,50 5,50 -279.773 10.917.578
2013-06-11 2013-06-07 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -5.102 109.441 -4,45 5,47 -27.893 598.325
2013-06-11 2013-06-07 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -94.898 2.035.771 -4,45 5,47 -518.817 11.129.764
2013-05-20 2013-05-17 4 THLD THRESHOLD PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 20.000 20.000
2013-01-31 2013-01-30 4 LPDX LIPOSCIENCE INC
Series F Convertible Preferred Stock
C - Conversion -25.261 0 -100,00
2013-01-31 2013-01-30 4 LPDX LIPOSCIENCE INC
Series F Convertible Preferred Stock
C - Conversion -534.339 0 -100,00
2013-01-31 2013-01-30 4 LPDX LIPOSCIENCE INC
Series E Convertible Preferred Stock
C - Conversion -41.509 0 -100,00
2013-01-31 2013-01-30 4 LPDX LIPOSCIENCE INC
Series E Convertible Preferred Stock
C - Conversion -878.030 0 -100,00
2013-01-31 2013-01-30 4 LPDX LIPOSCIENCE INC
Series D-1 Convertible Preferred Stock
C - Conversion -69.183 0 -100,00
2013-01-31 2013-01-30 4 LPDX LIPOSCIENCE INC
Series D-1 Convertible Preferred Stock
C - Conversion -1.463.385 0 -100,00
2013-01-31 2013-01-30 4 LPDX LIPOSCIENCE INC
Common Stock
P - Purchase 9.705 83.739 13,11 9,00 87.345 753.651
2013-01-31 2013-01-30 4 LPDX LIPOSCIENCE INC
Common Stock
P - Purchase 205.295 1.771.347 13,11 9,00 1.847.655 15.942.123
2013-01-31 2013-01-30 4 LPDX LIPOSCIENCE INC
Common Stock
C - Conversion 72.646 74.034 5.233,86
2013-01-31 2013-01-30 4 LPDX LIPOSCIENCE INC
Common Stock
C - Conversion 1.536.688 1.566.052 5.233,24
2013-01-24 3 LPDX LIPOSCIENCE INC
Common Stock
29.364
2013-01-24 3 LPDX LIPOSCIENCE INC
Common Stock
1.388
2012-12-11 2012-12-07 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock
P - Purchase 52.213 139.621 59,73 3,31 172.825 462.146
2012-12-11 2012-12-07 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock
P - Purchase 2.364.705 6.323.534 59,73 3,31 7.827.174 20.930.898
2012-09-06 2012-09-04 4 THLD THRESHOLD PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -12.500 20.000 -38,46
2012-09-06 2012-09-04 4 THLD THRESHOLD PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -12.500 20.000 -38,46
2012-09-06 2012-09-04 4 THLD THRESHOLD PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -10.000 45.000 -18,18
2012-09-06 2012-09-04 4 THLD THRESHOLD PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -10.000 45.000 -18,18
2012-09-06 2012-09-04 4 THLD THRESHOLD PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -2.500 55.000 -4,35
2012-09-06 2012-09-04 4 THLD THRESHOLD PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -2.500 55.000 -4,35
2012-09-06 2012-09-04 4 THLD THRESHOLD PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -2.500 57.500 -4,17
2012-09-06 2012-09-04 4 THLD THRESHOLD PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -2.500 60.000 -4,00
2012-09-06 2012-09-04 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
M - Exercise 12.500 55.000 29,41 1,64 20.500 90.200
2012-09-06 2012-09-04 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
M - Exercise 12.500 42.500 41,67 1,62 20.250 68.850
2012-09-06 2012-09-04 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
M - Exercise 10.000 30.000 50,00 1,95 19.500 58.500
2012-09-06 2012-09-04 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
M - Exercise 2.500 20.000 14,29 1,30 3.250 26.000
2012-09-06 2012-09-04 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
M - Exercise 2.500 20.000 14,29 1,30 3.250 26.000
2012-09-06 2012-09-04 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
M - Exercise 2.500 15.000 20,00 1,30 3.250 19.500
2012-09-06 2012-09-04 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
M - Exercise 2.500 12.500 25,00 1,30 3.250 16.250
2012-09-06 2012-09-04 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
M - Exercise 10.000 10.000 0,79 7.900 7.900
2012-08-27 2012-08-27 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -14.612 114.543 -11,31 7,98 -116.566 913.755
2012-08-27 2012-08-27 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -271.788 2.129.669 -11,32 7,98 -2.168.162 16.989.221
2012-08-27 2012-08-24 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -25.510 129.155 -16,49 8,02 -204.649 1.036.120
2012-08-27 2012-08-24 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -474.490 2.401.457 -16,50 8,02 -3.806.501 19.265.208
2012-08-23 2012-08-22 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -2.990 154.665 -1,90 7,52 -22.473 1.162.493
2012-08-23 2012-08-22 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -56.610 2.875.947 -1,93 7,52 -425.492 21.616.193
2012-08-23 2012-08-21 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -1.531 157.655 -0,96 7,50 -11.482 1.182.412
2012-08-23 2012-08-21 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -28.469 2.932.557 -0,96 7,50 -213.518 21.994.178
2012-08-10 2012-08-09 4 THLD THRESHOLD PHARMACEUTICALS INC
Warrant (right to buy)
X - Other -21.369 0 -100,00
2012-08-10 2012-08-09 4 THLD THRESHOLD PHARMACEUTICALS INC
Warrant (right to buy)
X - Other -20.007 21.369 -48,35
2012-08-10 2012-08-09 4 THLD THRESHOLD PHARMACEUTICALS INC
Warrant (right to buy)
X - Other -397.478 0 -100,00
2012-08-10 2012-08-09 4 THLD THRESHOLD PHARMACEUTICALS INC
Warrant (right to buy)
X - Other -372.149 397.478 -48,35
2012-08-10 2012-08-09 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
X - Other 21.369 159.186 15,51 2,05 43.806 326.331
2012-08-10 2012-08-09 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
X - Other 20.007 137.817 16,98 1,86 37.213 256.340
2012-08-10 2012-08-09 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
X - Other 397.478 2.961.026 15,50 2,05 814.830 6.070.103
2012-08-10 2012-08-09 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
X - Other 372.149 2.563.548 16,98 1,86 692.197 4.768.199
2012-07-17 2012-07-13 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -6.377 117.810 -5,13 8,01 -51.101 944.047
2012-07-17 2012-07-13 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -118.623 2.191.399 -5,14 8,01 -950.562 17.560.338
2012-06-06 2012-05-29 4/A ACRX ACELRX PHARMACEUTICALS INC
Warrant to purchase Common Stock
P - Purchase 4.151 4.151 0,12 519 519
2012-06-06 2012-05-29 4/A ACRX ACELRX PHARMACEUTICALS INC
Warrant to purchase Common Stock
P - Purchase 188.020 188.020 0,12 23.502 23.502
2012-06-06 2012-05-29 4/A ACRX ACELRX PHARMACEUTICALS INC
Warrant to purchase Common Stock
P - Purchase 3.268 3.268 0,12 408 408
2012-06-06 2012-05-29 4/A ACRX ACELRX PHARMACEUTICALS INC
Warrant to purchase Common Stock
P - Purchase 60.789 60.789 0,12 7.599 7.599
2012-06-06 2012-05-29 4/A ACRX ACELRX PHARMACEUTICALS INC
Common Stock
P - Purchase 4.613 87.408 5,57 3,40 15.684 297.187
2012-06-06 2012-05-29 4/A ACRX ACELRX PHARMACEUTICALS INC
Common Stock
P - Purchase 208.911 3.958.829 5,57 3,40 710.297 13.460.019
2012-06-06 2012-05-29 4/A ACRX ACELRX PHARMACEUTICALS INC
Common Stock
P - Purchase 3.631 199.174 1,86 3,40 12.345 677.192
2012-06-06 2012-05-29 4/A ACRX ACELRX PHARMACEUTICALS INC
Common Stock
P - Purchase 67.543 3.704.712 1,86 3,40 229.646 12.596.021
2012-05-31 2012-05-29 4 ACRX ACELRX PHARMACEUTICALS INC
Warrant to purchase Common Stock
P - Purchase 4.151 4.151 0,12 519 519
2012-05-31 2012-05-29 4 ACRX ACELRX PHARMACEUTICALS INC
Warrant to purchase Common Stock
P - Purchase 188.020 188.020 0,12 23.502 23.502
2012-05-31 2012-05-29 4 ACRX ACELRX PHARMACEUTICALS INC
Warrant to purchase Common Stock
P - Purchase 3.268 3.268 0,12 408 408
2012-05-31 2012-05-29 4 ACRX ACELRX PHARMACEUTICALS INC
Warrant to purchase Common Stock
P - Purchase 60.789 60.789 0,12 7.599 7.599
2012-05-31 2012-05-29 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock
P - Purchase 4.613 87.408 5,57 3,40 15.684 297.187
2012-05-31 2012-05-29 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock
P - Purchase 208.911 3.958.829 5,57 3,40 710.297 13.460.019
2012-05-31 2012-05-29 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock
P - Purchase 3.631 199.174 1,86 3,40 12.345 677.192
2012-05-31 2012-05-29 4 ACRX ACELRX PHARMACEUTICALS INC
Common Stock
P - Purchase 67.543 3.704.712 1,86 3,40 229.646 12.596.021
2012-05-21 2012-05-17 4 THLD THRESHOLD PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 20.000 20.000
2007-05-17 2007-05-16 4 THLD THRESHOLD PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 15.000 15.000
2006-03-07 2006-03-03 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
S - Sale -1.000.000 2.440.202 -29,07 14,50 -14.500.000 35.382.929
2005-02-10 2005-02-09 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
P - Purchase 11.939 175.491 7,30 7,00 83.573 1.228.437
2005-02-10 2005-02-09 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
P - Purchase 222.059 3.264.711 7,30 7,00 1.554.413 22.852.977
2005-02-03 2005-02-03 4 THLD THRESHOLD PHARMACEUTICALS INC
Series B Preferred Stock
C - Conversion -154.607 0 -100,00
2005-02-03 2005-02-03 4 THLD THRESHOLD PHARMACEUTICALS INC
Series B Preferred Stock
C - Conversion -2.875.696 0 -100,00
2005-02-03 2005-02-03 4 THLD THRESHOLD PHARMACEUTICALS INC
Series A Preferred Stock
C - Conversion -114.750 0 -100,00
2005-02-03 2005-02-03 4 THLD THRESHOLD PHARMACEUTICALS INC
Series A Preferred Stock
C - Conversion -2.135.250 0 -100,00
2005-02-03 2005-02-03 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
C - Conversion 93.877 163.552 134,74
2005-02-03 2005-02-03 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
C - Conversion 1.746.126 3.042.652 134,68
2005-02-03 2005-02-03 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
C - Conversion 69.675 69.675
2005-02-03 2005-02-03 4 THLD THRESHOLD PHARMACEUTICALS INC
Common Stock
C - Conversion 1.296.526 1.296.526
P
Acquisto sul mercato aperto o privato di un titolo non derivato o derivato
S
Vendita sul mercato aperto o privato di un titolo non derivato o derivato
A
Concessione, assegnazione o altra acquisizione di titoli dall'azienda (ad esempio un'opzione)
C
Conversione di un derivato
D
Vendita o trasferimento di titoli alla società
F
Pagamento del prezzo di esercizio o del debito fiscale con la quota di titoli ricevuta dalla società
G
Regalo di titoli da parte o a favore dell'insider
K
Equity swap e operazioni di copertura analoghe
M
Esercizio o conversione di un titolo derivato ricevuto dall'azienda (ad esempio un'opzione)
V
Una transazione dichiarata volontariamente sul modulo 4
J
Altro (accompagnato da una nota a piè di pagina che descriva l'operazione)